AURA
Price:
$8.95
Market Cap:
$443.97M
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2021-10-29
Stock Exchange
NASDAQ
Ticker
AURA
According to Aura Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -41.57%. This represents a change of 296.77% compared to the average of -10.48% of the last 4 quarters.
The mean historical ROE of Aura Biosciences, Inc. over the last ten years is -7.51%. The current -41.57% ROE has changed 453.21% with respect to the historical average. Over the past ten years (40 quarters), AURA's ROE was at its highest in in the June 2021 quarter at 7.21%. The ROE was at its lowest in in the December 2022 quarter at -21.38%.
Average
-7.51%
Median
-22.60%
Minimum
-33.83%
Maximum
27.69%
Discovering the peaks and valleys of Aura Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 29.48%
Maximum Annual ROE = 27.69%
Minimum Annual Increase = -210.62%
Minimum Annual ROE = -33.83%
Year | ROE | Change |
---|---|---|
2023 | -33.83% | 15.62% |
2022 | -29.26% | 29.48% |
2021 | -22.60% | -210.62% |
2020 | 20.43% | -26.23% |
The current ROE of Aura Biosciences, Inc. (AURA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-28.56%
5-year avg
-7.51%
10-year avg
-7.51%
Aura Biosciences, Inc.’s ROE is greater than Aerovate Therapeutics, Inc. (-90.19%), greater than Adagene Inc. (-50.10%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.95%), greater than Rezolute, Inc. (-69.83%), greater than AN2 Therapeutics, Inc. (-57.63%), greater than Seer, Inc. (-22.19%), greater than ORIC Pharmaceuticals, Inc. (-42.46%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than Cullinan Oncology, Inc. (-26.54%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Crinetics Pharmaceuticals, Inc. (-36.12%), greater than ALX Oncology Holdings Inc. (-93.02%), greater than Immatics N.V. (-15.98%), greater than BioAtla, Inc. (-187.30%), less than Opthea Limited (360.15%),
Company | ROE | Market cap |
---|---|---|
-90.19% | $76.81M | |
-50.10% | $97.11M | |
-47.95% | $202.87M | |
-69.83% | $284.50M | |
-57.63% | $39.99M | |
-22.19% | $143.29M | |
-42.46% | $676.74M | |
-184.40% | $37.86M | |
-26.54% | $730.17M | |
-42.45% | $300.00M | |
-36.12% | $5.20B | |
-93.02% | $74.37M | |
-15.98% | $905.91M | |
-187.30% | $75.90M | |
360.15% | $486.27M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aura Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aura Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Aura Biosciences, Inc.'s ROE?
How is the ROE calculated for Aura Biosciences, Inc. (AURA)?
What is the highest ROE for Aura Biosciences, Inc. (AURA)?
What is the 3-year average ROE for Aura Biosciences, Inc. (AURA)?
What is the 5-year average ROE for Aura Biosciences, Inc. (AURA)?
How does the current ROE for Aura Biosciences, Inc. (AURA) compare to its historical average?